医学
肺病
嗜酸性
病理
粘液
呼吸道疾病
免疫学
发病机制
肺
疾病
慢性阻塞性肺病
重症监护
呼吸系统
慢性病
并发症
作者
Federico Baraldi,Jordina Mah,Abdulrahman Almuhanna,Aaron Braddy-Green,Sam Bartlett‐Pestell,Mairi A MacLeod,Chloë I. Bloom,Andrew I. Ritchie,Dexter Wiseman,James P. Allinson,E A Hoffman,Alberto A. Papi,Jadwiga Anna Wedzicha,Lydia Finney
标识
DOI:10.1093/ajrccm/aamag311
摘要
Chronic obstructive pulmonary disease (COPD) is the fourth greatest cause of death worldwide. Airway mucus plugs (MP) are a novel biomarker of disease activity and are identified in 27% to 67% of patients with COPD. High MP score has been associated with greater airflow obstruction, increased risk of exacerbations, and mortality. However, the mechanisms underlying MP formation and composition have not been fully elucidated. In asthma, mucus plugging has been linked to eosinophil peroxidase (EPX), a cationic hemoprotein that promotes disulphide crosslinking between mucins validated as a biomarker of eosinophil activation. Blood eosinophil count (BEC) is a well-established biomarker in COPD, predicting response to inhaled corticosteroids and biologics targeting type 2 inflammation. Although an association between BEC values and MP score has been shown, the relationship between the activation state of airway eosinophils and MPs is unknown. We hypothesized that, in COPD, mucus plugging is associated with airway eosinophil activation, reflected by elevated sputum EPX (sEPX).
科研通智能强力驱动
Strongly Powered by AbleSci AI